1224917

Takeda Pharmaceutical Company Limited — FEI 3004664162

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 6, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hikari (Japan)